LLY80:BKK
Eli Lilly And Company KTB DR
1,98 ฿
arrow_upward
+1,54%(+0,030) 1D
13 қаз., 02:40:57 GMT+7 · THB
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for LLY80...
Open
1,98 ฿
High
1,99 ฿
Low
1,94 ฿
Mkt. cap
1,11 трлн
Avg. vol.
5,19 млн
Volume
2,46 млн
52-wk high
2,12 ฿
52-wk low
1,27 ฿
Shares outstanding
941,36 млн
No. of employees
50 мың
Open
1,98 ฿
High
1,99 ฿
Low
1,94 ฿
Mkt. cap
1,11 трлн
Avg. vol.
5,19 млн
Volume
2,46 млн
52-wk high
2,12 ฿
52-wk low
1,27 ฿
Shares outstanding
941,36 млн
No. of employees
50 мың
News stories
From web sources and news partners
The Globe and Mail
·
1 сағат бұрын
Eli Lilly Expects Up to $87 Billion in 2026 Revenue. Here's Why the Stock Still Looks Undervalued.
Yahoo Finance
·
4 сағат бұрын
Will Eli Lilly Do a Stock Split Before the End of 2026?
The Motley Fool
·
10 сағат бұрын
AbbVie vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026?
Indianapolis Business Journal
·
17 сағат бұрын
Lilly seeks to provide $19.3M to Lebanon for expanded hazmat services under proposed agreement
Profile
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 36 countries. Its products are marketed in approximately 90 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
About Eli Lilly And Company KTB DR
CEODavid A. Ricks
Employees50 мың
Founded1876
HeadquartersИндианаполис, Индиана, Америка Құрама Штаттары
SectorPharmaceutical industry
Websitelilly.com